Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| no clinical added value |
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients. |
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
kwhxjRjyCYPK7Afs
